How to Cite
Jim, H., Barata, A., Wenham, R., & Jacobsen, P. (2013). Fatigue, mood, and sleep, during intraperitoneal chemotherapy: a pilot case control study. International Journal of Psychological Research, 6(1), 8–14. https://doi.org/10.21500/20112084.694
License terms
The work that is sent to this journal must be original, not published or sent to be published elsewhere; and if it is accepted for publication, authors will agree to transfer copyright to International Journal of Psychological Research. 

To give up copyright, the authors allow that, International Journal of Psychological Research, distribute the work more broadly, check for the reuse by others and take care of the necessary procedures for the registration and administration of copyright; at the same time, our editorial board represents the interests of the author and allows authors to re-use his work in various forms. In response to the above, authors transfer copyright to the journal, International Journal of Psychological Research. This transfer does not imply other rights which are not those of authorship (for example those that concern about patents). Likewise, preserves the authors rights to use the work integral or partially in lectures, books and courses, as well as make copies for educational purposes. Finally, the authors may use freely the tables and figures in its future work, wherever make explicit reference to the previous publication in International Journal of Psychological Research. The assignment of copyright includes both virtual rights and forms of the article to allow the editorial to disseminate the work in the manner which it deems appropriate. 

The editorial board reserves the right of amendments deemed necessary in the application of the rules of publication.


The goal of this pilot study was to compare longitudinal changes in fatigue, depressive symptoms, sleep, and activity in women (n = 10) undergoing intraperitoneal (IP) versus intravenous (IV) chemotherapy for ovarian cancer. Fatigue and depressive symptoms were assessed via self –report and sleep and activity via wrist actigraphy in the week before and the week after the first infusion. Both groups demonstrated increases in fatigue and depressive symptoms, declines in sleep, reduced daytime activity, and decreased rhythmicity of sleep/activity patterns (p<.05). Effect sizes for within-group comparisons tended to be higher in the IP group (ds = -.15 to -8.03) than the IV group (ds = .12 to 1.40). Between-group comparisons revealed that IP patients demonstrated trends towards more severe symptoms post-chemotherapy in nearly all outcomes (p<.10). These results suggest that IP patients experience large increases in fatigue, depressive symptoms, and alterations in sleep and activity relative to IV patients.



Alberts, D. S., Liu, P. Y., Hannigan, E .V., O'Toole, R., Williams, S. D., Young, J. A,.…Malviya,V. K. (1996). Intraperitoneal cisplatin plus intraneous cyclophosphamide for stage III ovarian cancer. The New England Journal of
Medicine, 335(26), 1950-1955.
Alberts, D. S., Markman, M., Muggia, F., Ozols, R. F., Eldermire, E., Bookman, M. A. … Trimble E. (2006). Proceedings of a GOG workshop on intraperitoneal therapy for ovarian cancer. Gynecologic Oncology, 103(3), 783-792.
Anderson, N. J. & Hacker E. D. (2008). Fatigue in women receiving intraperitoneal chemotherapy for ovarian cancer: a review of contributing factors. Clinical Journal of Oncology Nursing, 12(3), 445-454.
Andresen, E. M., Malmgren, J. A., Carter, W. B. & Patrick, D. L. (1994). Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale). American Journal of Preventive Medicine, 10(2), 77-84.
Armstrong, D. K., Bundy, B., Wenzel, L., Huang, H. Q., Baergen, R., Lele, S. … Gynecologic Oncology Group. (2006). Intraperitoneal cisplatin and paclitaxel in ovarian cancer. The New England Journal of Medicine, 354(1), 34-43.
Armstrong, D. K. & Brady M. F. (2006). Intraperitoneal therapy for ovarian cancer: a treatment ready for prime time. Journal of Clinical Oncology, 24(28), 4531-4533.
Berger, A. M., Wielgus, K. K., Young-McCaughan, S., Fischer, P., Farr, L. & Lee, K. A. (2008). Methodological challenges when using actigraphy in research. Journal of Pain and Symptom Management, 36(2), 191-199.
Berger, A. M., Abernethy, A., Atkinson, A., Barsevick, A., Breitbart, W. S., Cella, D. … Wagner, L. L. (2009). NCCN Clinical Practice Guidelines in Oncology: Cancer-Related Fatigue Available from: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp.
Cohen, J. (1988) Statistical power for the behavioral sciences. Hillsdale, NJ: Lawrence Erlbaum Associates.
Elit, L., Oliver, T. K., Covens, A., Kwon, J., Fung, M. F., Hirte, H. W. & Oza, A. M. (2007). Intraperitoneal chemotherapy in the first-line treatment of women with stage III epithelial ovarian cancer: a systematic review with metaanalyses. Cancer, 109(4), 692-702.
Frost, M. H., Bonomi, A. E., Cappelleri, J. C., Schünemann, H. J., Moynihan, T. J., Aaronson, N. K., & Clinical Significance Consensus Meeting Group. (2007). Applying quality-of-life data formally and systematically into clinical practice. Mayo Clinic Proceedings, 82(10), 1214-1228.
Gore, M., Du Bois, A. & Vergote, I. (2006). Intraperitoneal chemotherapy in ovarian cancer remains experimental. Journal of Clinical Oncology, 24(28), 4528-4530.
Hann, D. M., Jacobsen, P. B., Azzarello, L. M., Martin, S. C., Curran, S. L., Fields, K. K. … Lyman G. (1998). Measurement of fatigue in cancer patients: development and validation of the Fatigue Symptom Inventory. Quality of Life Research, 7(4) 301-310.


Download data is not yet available.

Cited by